1-12 of 12
Karen-Sue Carlson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CNS Status at Diagnosis Can Identify Acute Myeloid Leukemia Patients with Poor Induction Outcomes

Kristine Broge-Reynen, Emily Giever, Aniko Szabo, Ryan Conrardy, Nicole M Held, Laura C. Michaelis, Lyndsey Runaas, Sameem Abedin, Guru Subramanian Guru Murthy, Karen-Sue Carlson, Ravi Kishore Narra, Sumana Devata, Sheila Swartz, Valarie Ehrlich, Mary Rodgers, Allison Johnson, Ehab L. Atallah
Journal: Blood
Blood (2024) 144 (Supplement 1): 5173.
https://doi.org/10.1182/blood-2024-208834
Published: 2024
Journal Articles

Outcome of Patients with TP53 Mutated Relapsed/Refractory AML with Lintuzumab-Ac225 in Combination with CLAG-M Following Venetoclax Plus Hypomethylating Agent Therapy

Sameem Abedin, Guru Subramanian Guru Murthy, Mehdi Hamadani, Laura C. Michaelis, Karen-Sue Carlson, Lyndsey Runaas, Katelyn Gauger, Avinash Desai, Mary Chen, Patrik Brodin, Kate L Li, Mojisola Rotibi, Umar Sayeed, Alexandra M. Harrington, Ehab L. Atallah
Journal: Blood
Blood (2024) 144 (Supplement 1): 4258.
https://doi.org/10.1182/blood-2024-201559
Published: 2024
Journal Articles

MiR-9-1 Controls Osteoblastic Regulation of Lymphopoiesis

Yongguang Zhang, Yongwei Zheng, Yuhong Chen, Mei Yu, Karen-Sue Carlson, Renren Wen, Demin Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1333.
https://doi.org/10.1182/blood-2023-181128
Published: 2023
Journal Articles

Analysis of Factors Associated with Increased Hematology/Oncology Fellowship Twitter Account Followership

Chandrasekar Muthiah, Shabi Haider, Chapman Wei, Karen-Sue Carlson
Journal: Blood
Blood (2023) 142 (Supplement 1): 7231.
https://doi.org/10.1182/blood-2023-178331
Published: 2023
Journal Articles

Outcomes of Patients Treated with Low-Intensity Re-Induction Therapy for Persistent Disease after a Single Intensive Induction Cycle for Newly Diagnosed Acute Myeloid Leukemia (AML)

Sameem Abedin, Skyler Taylor, Guru Subramanian Guru Murthy, Lyndsey Runaas, Laura C. Michaelis, Karen-Sue Carlson, Ehab L. Atallah
Journal: Blood
Blood (2022) 140 (Supplement 1): 11020–11021.
https://doi.org/10.1182/blood-2022-160416
Published: 2022
Journal Articles

Single Center, Retrospective Study on the Effect of Mirabegron, a Beta3-Adrenergic Receptor Agonist, on Total Lymphocyte Numbers in the Peripheral Blood

Jordan R. Hanrahan, Abigail Thorgerson, Kristen Osinski, Karen-Sue Carlson
Journal: Blood
Blood (2022) 140 (Supplement 1): 11428–11429.
https://doi.org/10.1182/blood-2022-163498
Published: 2022
Journal Articles

Lintuzumab-Ac225 with Combination with Intensive Chemotherapy Yields High Response Rate and MRD Negativity in R/R AML with Adverse Features

Sameem Abedin, Guru Subramanian Guru Murthy, Aniko Szabo, Mehdi Hamadani, Laura C. Michaelis, Karen-Sue Carlson, Lyndsey Runaas, Katelyn Gauger, Avinash G Desai, Mary M Chen, Alexandra M. Harrington, Ehab L. Atallah
Journal: Blood
Blood (2022) 140 (Supplement 1): 157–158.
https://doi.org/10.1182/blood-2022-157827
Published: 2022
Journal Articles

Standardized Communication Tool Improves Inpatient-Outpatient Care Transitions for Adults with Acute Leukemia

Jordan R. Hanrahan, Leroy J. Seymour, Anna Beckius, Donna Welter, Mandy Kastner, Valarie Ehrlich, Kristine Broge-Reynen, Mary Rodgers, Laura C. Michaelis, Lyndsey Runaas, Ehab L. Atallah, Sameem Abedin, Guru Subramanian Guru Murthy, Ravi Kishore Narra, Mary Fournogerakis, Jessica Schmitz, Andrea Viitala, Elizabeth Larsen, Amber Essenmacher, Gina George, Kim Johnston, Karen Sue Carlson, Nicole Held
Journal: Blood
Blood (2022) 140 (Supplement 1): 5083–5085.
https://doi.org/10.1182/blood-2022-159809
Published: 2022
Journal Articles

Assessment of Comorbidities and Their Association with Outcomes in Adults with Acute Lymphoblastic Leukemia (ALL)Using Various Comorbidity-Based Scoring Systems

Ravi Kishore Narra, Ehab L. Atallah, Laura C. Michaelis, Karen-Sue Carlson, Lyndsey Runaas, Aniko Szabo, Guru Subramanian Guru Murthy
Journal: Blood
Blood (2022) 140 (Supplement 1): 6035–6036.
https://doi.org/10.1182/blood-2022-165392
Published: 2022
Journal Articles

A Phase I Study of Lintuzumab Ac225 in Combination with CLAG-M Chemotherapy in Relapsed/Refractory AML

Sameem Abedin, MD, Guru Subramanian Guru Guru Murthy, MBBS, Mehdi Hamadani, MD, Laura C. Michaelis, MD, Lyndsey Runaas, MD, Karen-Sue Carlson, MDPhD, Alexandra M. Harrington, MDMT(ASCP), Ehab L. Atallah, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–10.
https://doi.org/10.1182/blood-2020-137218
Published: 2020
Journal Articles

Dependence on Schwann Cell-Derived Laminin-γ1 Differentiates Early Lymphoid and Myeloid Development

Kristin Komnick, MPH, Jennifer May, Pouneh Kermani, PhD, Sreemanti Basu, PhD, Irene Hernandez, Mark Zogg, BS, British L Fields, Joshua Morris, MD, Hartmut Weiler, PhD, Karen-Sue Carlson, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37.
https://doi.org/10.1182/blood-2020-142860
Published: 2020
Journal Articles

Secondary Hematologic Malignancies after Autologous Stem Cell Transplantation for Multiple Myeloma Are Associated with a Distinct Mutational Profile

Ariel Kleman, MD, Arun K Singavi, MD MS, Lauren Pommert, MDMS, Michael T Zimmerman, PhD, Wendy Demos, Angela Mathison, PhD, Sridhar Rao, MDPhD, Karen-Sue Carlson, MDPhD, Parameswaran Hari, MD MRCP
Journal: Blood
Blood (2020) 136 (Supplement 1): 28.
https://doi.org/10.1182/blood-2020-142410
Published: 2020